A similar significant reduction of CD45+/CD19+/ROR1+ cells was also noted when CLL cells harboring del(17p) were transplanted but not as marked as for non-del(17p) CLL cells. This evidence concerns the gene ROR1 and B-cell chronic lymphocytic leukemia.